← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FLORIDA · Approved 2020-02-19

Drug application

FDA Application #
ANDA208637
Application type
Abbreviated New Drug Application (Generic)
Brand name
OLOPATADINE HYDROCHLORIDE
Generic name
Olopatadine Hydrochloride
Active ingredients
OLOPATADINE HYDROCHLORIDE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
FLORIDA
First approval
2020-02-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown